Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Julia Bitencourt"'
Autor:
Rachel Tanner, Andrew D. White, Charelle Boot, Claudia C. Sombroek, Matthew K. O’Shea, Daniel Wright, Emily Hoogkamer, Julia Bitencourt, Stephanie A. Harris, Charlotte Sarfas, Rachel Wittenberg, Iman Satti, Helen A. Fletcher, Frank A. W. Verreck, Sally A. Sharpe, Helen McShane
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract We present a non-human primate mycobacterial growth inhibition assay (MGIA) using in vitro blood or cell co-culture with the aim of refining and expediting early tuberculosis vaccine testing. We have taken steps to optimise the assay using c
Externí odkaz:
https://doaj.org/article/68af0e0e83b24984a10595f180e34dba
Autor:
Julia Bitencourt, Marco Polo Peralta-Álvarez, Morven Wilkie, Ashley Jacobs, Daniel Wright, Salem Salman Almujri, Shuailin Li, Stephanie A. Harris, Steven G. Smith, Sean C. Elias, Andrew D. White, Iman Satti, Sally S. Sharpe, Matthew K. O’Shea, Helen McShane, Rachel Tanner
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Tuberculosis (TB) is a major global health problem and the only currently-licensed vaccine, BCG, is inadequate. Many TB vaccine candidates are designed to be given as a boost to BCG; an understanding of the BCG-induced immune response is therefore cr
Externí odkaz:
https://doaj.org/article/048b6deb508042c9b23e2a2b29903bc3
Publikováno v:
Genetics and Molecular Biology, Vol 44, Iss 4 (2021)
Abstract Despite highly variable efficacy, BCG (Bacillus Calmette-Guérin) is the only vaccine available to prevent the tuberculosis (TB). Genomic heterogeneity between attenuated BCG strains and virulent Mycobacterium tuberculosis might help to expl
Externí odkaz:
https://doaj.org/article/a9792c320766400999f0100efed843d0
Autor:
Rachel Tanner, Emily Hoogkamer, Julia Bitencourt, Andrew White, Charelle Boot, Claudia C. Sombroek, Stephanie A. Harris, Matthew K. O'Shea, Daniel Wright, Rachel Wittenberg, Charlotte Sarfas, Iman Satti, Frank A.W. Verreck, Sally A. Sharpe, Helen A. Fletcher, Helen McShane
Publikováno v:
F1000Research, Vol 10 (2021)
The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulen
Externí odkaz:
https://doaj.org/article/f4d160f312314877839761de896f12a2
Autor:
Rachel Tanner, Emily Hoogkamer, Julia Bitencourt, Andrew White, Charelle Boot, Claudia C. Sombroek, Stephanie A. Harris, Matthew K. O'Shea, Daniel Wright, Rachel Wittenberg, Charlotte Sarfas, Iman Satti, Frank A.W. Verreck, Sally A. Sharpe, Helen A. Fletcher, Helen McShane
Publikováno v:
F1000Research, Vol 10 (2021)
The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulen
Externí odkaz:
https://doaj.org/article/8d457b8383a642419000e0f51934d0e4
Autor:
Welter, Júlia Bitencourt, Simonaggio, Matheus Fell, da Silva, Salatiel Wohlmuth, Martí-Calatayud, Manuel César, Pérez-Herranz, Valentín, Ferreira, Jane Zoppas
Publikováno v:
In Journal of Water Process Engineering August 2022 48
Publikováno v:
In Journal of Environmental Chemical Engineering February 2018 6(1):1390-1395
Publikováno v:
Procedia Computer Science. 200:111-120
Autor:
Rachel, Tanner, Emily, Hoogkamer, Julia, Bitencourt, Andrew, White, Charelle, Boot, Claudia C, Sombroek, Stephanie A, Harris, Matthew K, O'Shea, Daniel, Wright, Rachel, Wittenberg, Charlotte, Sarfas, Iman, Satti, Frank A W, Verreck, Sally A, Sharpe, Helen A, Fletcher, Helen, McShane
Publikováno v:
F1000Research
The only currently available approach to early efficacy testing of tuberculosis (TB) vaccine candidates is in vivo preclinical challenge models. These typically include mice, guinea pigs and non-human primates (NHPs), which must be exposed to virulen
Autor:
Steven G. Smith, Ashley Jacobs, Daniel B. Wright, Sally Sharpe, Julia Bitencourt, Andrew White, Rachel Tanner, Morven Wilkie, Helen McShane, Sean C. Elias, Stephanie A. Harris, Marco Polo Peralta Alvarez, Matthew K. O'Shea
Many tuberculosis (TB) vaccine candidates are designed as a boost to BCG; an understanding of the BCG-induced immune response is therefore critical, and the opportunity to relate this to circumstances where BCG does protect may direct the design of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5c65bc9d3f5726b54045277afbea50f
https://doi.org/10.1101/2021.02.18.431837
https://doi.org/10.1101/2021.02.18.431837